Soleno Therapeutics Inc (SLNO) financials · rev $190.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Soleno Therapeutics Inc (SLNO) rev $190.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $190.4M | N/A |
| Cost of Revenue | $2.70M | N/A |
| Gross Profit | $187.7M | N/A |
| Operating Income | $9.41M | -$187.7M |
| Net Income | $20.9M | -$175.8M |
| EPS (Diluted) | $0.39 | -$4.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $563.8M | $331.0M |
| Current Assets | $355.8M | $293.9M |
| Cash & Equivalents | $70.1M | $87.9M |
| Inventory | $15.0M | N/A |
| PP&E | $185.0K | $186.0K |
| Total Liabilities | $113.7M | $85.9M |
| Current Liabilities | $61.4M | $18.7M |
| Long-term Debt | $49.8M | $49.8M |
| Total Debt | $49.8M† | $49.8M† |
| Shareholders' Equity | $450.1M | $245.1M |
| Retained Earnings | -$431.4M | -$452.3M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $46.8M | -$69.1M |
| CapEx | $73.0K | $218.0K |
| Investing Cash Flow | -$201.8M | -$225.7M |
| Financing Cash Flow | $137.2M | $213.0M |
| Net Change in Cash | -$17.8M | -$81.8M |
| Free Cash Flow | $46.7M | -$69.3M |
FAQ
What is SLNO P/E and revenue?
Soleno Therapeutics Inc (SLNO) rev $190.4M.
What is SLNO revenue?
Soleno Therapeutics Inc last cached revenue is $190.4M (FY2025).
Is SLNO profitable?
Soleno Therapeutics Inc last cached net income is $20.9M (FY2025).
What are SLNO total assets?
Soleno Therapeutics Inc last cached total assets are $563.8M (FY2025).
What is SLNO free cash flow?
Soleno Therapeutics Inc last cached free cash flow is $46.7M (FY2025).
Not investment advice. Cached statements, not a live tape.